TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11788642

Group type: COMPARATOR
Intervention: 1 mg oral dexamethasone test
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 0.0035 mg oral dexamethasone per kg
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 0.0070 mg oral dexamethasone per kg
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 0.015 mg oral dexamethasone per kg
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All variable-dose tests
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All tests
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Stepwise multiple regression analysis
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 121
Study: 10784385

Group type: EXPERIMENTAL
Intervention: Corn oil diet (80 g of corn oil, 20 mg alpha‐tocopherol, 100 mg gamma‐tocopherol)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Olive/sunflower oil diet (80 g of olive/sunflower oil, 24 mg alpha‐tocopherol, 2.4 mg gamma‐tocopherol)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Corn oil diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Olive/sunflower oil diet
Number of subjects: 20
Study: 7746909

Group type: EXPERIMENTAL
Intervention: Salbutamol powder (1.6 mg) from the Diskhaler
Number of subjects: 32

Group type: COMPARATOR
Intervention: Salbutamol nebulizer solution (2.5 ml, 1 mg ml‐1) from a jet nebulizer
Number of subjects: 32
Study: 2117011

Group type: EXPERIMENTAL
Intervention: Brooker-Wills femoral nail
Number of subjects: 70

Group type: COMPARATOR
Intervention: Russell-Taylor femoral nail
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study: 6785790

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) at fixed doses (200, 400, or 600 mg)
Number of subjects: 43
Study: 31170973

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for postpartum diabetes prevention
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Health educators and interviewers' involvement in intervention implementation
Number of subjects: 8
Study: 28063397

Group type: EXPERIMENTAL
Intervention: Antipsychotic medications
Number of subjects: 159
Study: 26457673

Group type: EXPERIMENTAL
Intervention: Antioxidant glasses containing extracts of medicinal plants
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo glasses
Number of subjects: 50
Study: 23420053

Group type: EXPERIMENTAL
Intervention: TachoSil®
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard treatment (stapling/suturing)
Number of subjects: 24
Study: 21894690

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo-Acupuncture Control
Number of subjects: 118
Study: 19430405

Group type: EXPERIMENTAL
Intervention: Biochemotherapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Interferon-alpha-2b (IFN)
Number of subjects: 138
Study: 16169641

Group type: EXPERIMENTAL
Intervention: Masai barefoot technology shoes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regular shoes
Number of subjects: 12
Study: 15260862

Group type: EXPERIMENTAL
Intervention: Coresidence with adult relatives
Number of subjects: 554

Group type: COMPARATOR
Intervention: Extended households
Number of subjects: 554
Study: 10902294

Group type: EXPERIMENTAL
Intervention: self-hypnosis
Number of subjects: 169

Group type: COMPARATOR
Intervention: autogenic training
Number of subjects: 169
Study: 9286853

Group type: COMPARATOR
Intervention: Mibefradil 50 mg
Number of subjects: 3430

Group type: COMPARATOR
Intervention: Mibefradil 100 mg
Number of subjects: 3430

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3430

Group type: EXPERIMENTAL
Intervention: Mibefradil
Number of subjects: 3430

Group type: COMPARATOR
Intervention: Mibefradil 50 mg and 100 mg
Number of subjects: 3430
Study: 8393637

Group type: EXPERIMENTAL
Intervention: Atrial Natriuretic Peptide (ANP) infusion at 5 ng/kg/min
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atrial Natriuretic Peptide (ANP) infusion
Number of subjects: 11
Study: 2947777

Group type: EXPERIMENTAL
Intervention: 100 mg DMPA
Number of subjects: 1216

Group type: EXPERIMENTAL
Intervention: 150 mg DMPA
Number of subjects: 1216
Study: 31176889

Group type: EXPERIMENTAL
Intervention: Unguided web-based intervention
Number of subjects: 724

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 724
Study: 30530872

Group type: EXPERIMENTAL
Intervention: STEP (Coordinated Specialty Care)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual Treatment (UT)
Number of subjects: 30
Study: 26901242

Group type: EXPERIMENTAL
Intervention: Nonlinear resistance training (NLRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 24974240

Group type: EXPERIMENTAL
Intervention: Psoriasis and Arthritis Screening Questionnaire (PASQ)
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Psoriasis Epidemiology Screening Tool (PEST)
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Toronto Psoriatic Arthritis Screen (ToPAS)
Number of subjects: 949
Study: 23161187

Group type: EXPERIMENTAL
Intervention: Magnetic resonance spectroscopy in cirrhotic patients
Number of subjects: 91
Study: 20123224

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation at 2 L/min via nasal cannulae overnight
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (room air)
Number of subjects: 63
Study: 17406348

Group type: EXPERIMENTAL
Intervention: Brief smoking cessation advice supplemented with written information during cervical smear test appointments
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (no smoking cessation advice)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Brief smoking cessation advice
Number of subjects: 242
Study: 16363902

Group type: COMPARATOR
Intervention: Balloon Angioplasty (BA)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Balloon Angioplasty with adjunctive endovascular brachytherapy (BA+EVBT)
Number of subjects: 147
Study: 12225549

Group type: EXPERIMENTAL
Intervention: Postnatal MgSO(4) infusion (250 mg/kg per day) for 3 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no MgSO(4) infusion)
Number of subjects: 33
Study: 9857278

Group type: EXPERIMENTAL
Intervention: Exercise training for 8 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 17
Study: 7883833

Group type: EXPERIMENTAL
Intervention: Desipramine (75 mg, orally)
Number of subjects: 8
Study: 2556909

Group type: EXPERIMENTAL
Intervention: All Bran
Number of subjects: 11

Group type: COMPARATOR
Intervention: Corn Flakes
Number of subjects: 11
Study: 860138

Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 milligram)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 7
Study: 31488204

Group type: EXPERIMENTAL
Intervention: Socioemotional and material learning paradigm (SEMLA)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Digitally implemented attention and math training paradigm (DIL)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Follow-up analysis
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Background variables
Number of subjects: 431
Study: 29214926

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT, n = 31)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Low-Intensity Training (LIT, n = 31)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control Group (CG, n = 45)
Number of subjects: 107
Study: 25738891

Group type: EXPERIMENTAL
Intervention: Web-based counselor-assisted family problem-solving therapy (CAPS)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Internet resource comparison (IRC)
Number of subjects: 132
Study: 23040589

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES-R)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 40
Study: 21609212

Group type: EXPERIMENTAL
Intervention: Emervel Classic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restylane
Number of subjects: 0
Study: 18713189

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for weight loss
Number of subjects: 1388

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1388
Study: 16249666

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bispectral Index
Number of subjects: 40
Study: 11850141

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (0, 10, 20, 30, 40% N(2)O in O(2))
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (active doses)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (100% O(2))
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-drug option
Number of subjects: 20
Study: 10092569

Group type: EXPERIMENTAL
Intervention: Ventricular pacing (n = 115)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Atrial pacing (n = 110)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Left atrial size measured by M mode echocardiography
Number of subjects: 225
Study: 7569304

Group type: EXPERIMENTAL
Intervention: Using a wheelchair as a simulation activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 2168762

Group type: EXPERIMENTAL
Intervention: Estrogen treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7357376

Group type: EXPERIMENTAL
Intervention: Recognition Memory (RM) group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Semantic Classification (SC) group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 30191781

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 67
Study: 28225313

Group type: EXPERIMENTAL
Intervention: Testosterone gel 2% (Tgel) 23 mg/day, uptitrated to 46 mg/day after 2 weeks if necessary, with further adjustments possible on Days 21, 42, and 63.
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Testosterone gel 2% (Tgel)
Number of subjects: 159
Study: 26241569

Group type: EXPERIMENTAL
Intervention: Online (ONL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 32
Study: 23541791

Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroquine and/or Proguanil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atovaquone/Proguanil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unexposed travelers
Number of subjects: 0
Study: 21813914

Group type: EXPERIMENTAL
Intervention: Lactate (120 mg/kg body mass)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (equal volume)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 11
Study: 19114909

Group type: EXPERIMENTAL
Intervention: Furosemide (0.5 mg/kg/hr)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 16719027

Group type: EXPERIMENTAL
Intervention: Therapeutic strapping
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo strapping
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Range of movement and function
Number of subjects: 33
Study: 15837997

Group type: EXPERIMENTAL
Intervention: BMS‐275291, 1,200 mg orally daily
Number of subjects: 774

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 774
Study: 12222541

Group type: EXPERIMENTAL
Intervention: Hartford Hospital nomogram
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Barnes‐Jewish Hospital nomogram
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: University of Rochester nomogram
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sanford Guide nomogram
Number of subjects: 90
Study: 10483132

Group type: EXPERIMENTAL
Intervention: General population and medical practitioners
Number of subjects: 14063

Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 14063

Group type: EXPERIMENTAL
Intervention: Medical practitioners
Number of subjects: 14063

Group type: EXPERIMENTAL
Intervention: Doctors
Number of subjects: 14063

Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 14063
Study: 7605852

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg b.d. for 4 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Etodolac 400 mg b.d. for 4 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo b.d. for 4 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Naproxen (1 week)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Etodolac (1 week)
Number of subjects: 52
Study: 2193640

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 40
Study: 378040

Group type: EXPERIMENTAL
Intervention: Triprolidine 2.5 mg t.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Triprolidine 1.25 mg t.i.d.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30565155

Group type: EXPERIMENTAL
Intervention: 100 mg enteric-coated aspirin once daily
Number of subjects: 7971
Study: 28207724

Group type: EXPERIMENTAL
Intervention: Green Prescription plus Kia Ākina (KA/GRx)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Green Prescription alone (GRx)
Number of subjects: 108
Study: 25919061

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg bid
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Placebo (with standard care)
Number of subjects: 5000
Study: 23599013

Group type: EXPERIMENTAL
Intervention: Shang Ring (SR)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Forceps-guided AMC
Number of subjects: 138
Study: 21852629

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (standard care plus 12 months of telephone counseling and tailored newsletters)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 266
Study: 19320574

Group type: EXPERIMENTAL
Intervention: 1.5 minutes of surgical hand antisepsis with alcohol-based hand rub (45% vol/vol 2-propanol, 30% vol/vol 1-propanol, and 0.2% mecetronium ethylsulphate)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 3 minutes of surgical hand antisepsis with alcohol-based hand rub (45% vol/vol 2-propanol, 30% vol/vol 1-propanol, and 0.2% mecetronium ethylsulphate)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 1.5 minutes of surgical hand antisepsis with alcohol-based hand rub
Number of subjects: 32

Group type: COMPARATOR
Intervention: 3 minutes of surgical hand antisepsis with alcohol-based hand rub
Number of subjects: 32
Study: 17650781

Group type: EXPERIMENTAL
Intervention: Self-efficacy expectations and outcome expectations related to exercise
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Self-efficacy expectations
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Age and mental status or depressive symptoms
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Age, cognitive status, physical and mental health status, pain, fear, outcome expectations, and depressive symptoms
Number of subjects: 389
Study: 14739148

Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (ABLC) 3 mg/kg/day every 21 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 17
Study: 11465701

Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg/day)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Folinic acid (2.5 mg/week)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg/day) and Folinic acid (2.5 mg/week)
Number of subjects: 434
Study: 9930426

Group type: EXPERIMENTAL
Intervention: Hancock valves (group A)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Stentless bioprostheses (group B)
Number of subjects: 77
Study: 8067370

Group type: EXPERIMENTAL
Intervention: Oral support
Number of subjects: 13

Group type: COMPARATOR
Intervention: No oral support
Number of subjects: 13
Study: 2904462

Group type: EXPERIMENTAL
Intervention: Mezlocillin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cefuroxime plus metronidazole
Number of subjects: 50
Study: 31444908

Group type: EXPERIMENTAL
Intervention: DBBM‐C with NBCM (test group 1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DBBM‐C only (test group 2)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Natural healing (control group)
Number of subjects: 3
Study: 30443174

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation with volume guarantee (PCV with VG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1:1 equal ratio ventilation (ERV)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (PCV with VG and ERV)
Number of subjects: 80
Study: 27187451

Group type: EXPERIMENTAL
Intervention: Whey Protein supplementation (WP, n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Food Protein sources (FP, n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Whey Protein supplementation (WP, n = 9)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Food Protein sources (FP, n = 12)
Number of subjects: 30
Study: 25335089

Group type: EXPERIMENTAL
Intervention: Real-time force feedback
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Postprocessing force feedback
Number of subjects: 72

Group type: COMPARATOR
Intervention: No force feedback (control)
Number of subjects: 72
Study: 22234322

Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Relaxation training
Number of subjects: 21
Study: 20184572

Group type: EXPERIMENTAL
Intervention: Vardenafil (group A)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sildenafil (group B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: L-carnitine (group C)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No treatment (group D)
Number of subjects: 75
Study: 17277732

Group type: EXPERIMENTAL
Intervention: Patients with paranoid schizophrenia
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Patients with unipolar depression
Number of subjects: 105

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 105
Study: 16238703

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14507127

Group type: EXPERIMENTAL
Intervention: Kinetic cavity preparation (KCP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rotating instruments
Number of subjects: 0
Study: 10090440

Group type: EXPERIMENTAL
Intervention: Antihistamines (fexofenadine or loratadine) for 2 weeks after 1 week of placebo
Number of subjects: 569

Group type: COMPARATOR
Intervention: Placebo for 1 week
Number of subjects: 569
Study: 8525693

Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination with inactivated uropathogenic bacteria (Solco‐Urovac)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-immunized control group (age-matched girls with UTI)
Number of subjects: 10
Study: 2180234

Group type: EXPERIMENTAL
Intervention: Two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules
Number of subjects: 82543

Group type: EXPERIMENTAL
Intervention: One dose of Ty21a Salmonella typhi vaccine in enteric-coated capsules
Number of subjects: 82543

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82543

Group type: EXPERIMENTAL
Intervention: Ty21a Salmonella typhi vaccine (both doses)
Number of subjects: 82543
Study: 548940

Group type: EXPERIMENTAL
Intervention: 1 g cefaclor orally
Number of subjects: 25

Group type: COMPARATOR
Intervention: 1 g cephalexin orally
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 0.5 g cefaclor orally 4 times daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 1 g cefaclor (single dose)
Number of subjects: 25
Study: 31637815

Group type: EXPERIMENTAL
Intervention: Phenogroup 1 (higher burden of co-morbidities, natriuretic peptides, and abnormalities in left ventricular structure and function)
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Phenogroup 2 (lower prevalence of cardiovascular and non-cardiac co-morbidities but higher burden of diastolic dysfunction)
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Phenogroup 3 (lower natriuretic peptide levels, intermediate co-morbidity burden, and most favorable diastolic function profile)
Number of subjects: 1767
Study: 31427862

Group type: EXPERIMENTAL
Intervention: Exercise training at maximal fat oxidation intensity (FATmax), 3 days/week for 1 hour/day for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise training at maximal fat oxidation intensity (FATmax)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 28981875

Group type: EXPERIMENTAL
Intervention: Active rTMS (10-Hz applied to the left dorsolateral prefrontal cortex, 5 days per week for 21 days)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham rTMS (10-Hz applied to the left dorsolateral prefrontal cortex, 5 days per week for 21 days)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Active rTMS predictor in sham-treated patients
Number of subjects: 92
Study: 27724923

Group type: EXPERIMENTAL
Intervention: Daily probiotics (four capsules of Vivomixx®; total of 450 billion CFU/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24526141

Group type: EXPERIMENTAL
Intervention: NCE 4D MRA with STAR spin labeling and variable flip angle sampling
Number of subjects: 9
Study: 23964444

Group type: EXPERIMENTAL
Intervention: NSAIDs (diclofenac) 75 mg/d with curcumin 1,000 mg/d for 3 months
Number of subjects: 88

Group type: COMPARATOR
Intervention: NSAIDs (diclofenac) 75 mg/d with placebo
Number of subjects: 88
Study: 20185666

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline (HTS)
Number of subjects: 238

Group type: COMPARATOR
Intervention: 20% mannitol
Number of subjects: 238
Study: 17657838

Group type: EXPERIMENTAL
Intervention: Triple therapy of lafutidine, clarithromycin, and amoxicillin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triple therapy of lansoprazole, clarithromycin, and amoxicillin
Number of subjects: 40
Study: 15662503

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with verteporfin
Number of subjects: 20